2794195-73-4
2794195-73-4
Chemical Structure
Nomelcitinib
- CAS No.: 2794195-73-4
- Formula:C16H14D3ClN6O4S
- Molecular Weight:427.88
InChIKey: QZZGWCBTIULDRA-FIBGUPNXSA-N
SMILES: [2H]C([2H])([2H])NC(C(N=NC(NC(C1CC1)=O)=C2)=C2NC3=C(C=C(C=N3)Cl)S(C)(=O)=O)=O
Biological Activity: Nomelcitinib is a TYK2 inhibitor that modulates the IL23 signaling pathway. Nomelcitinib is used for research on multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, psoriasis, psoriatic arthritis, Crohn's disease, Sjögren's syndrome, and scleroderma[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nomelcitinib | Nomelcitinib is a TYK2 inhibitor that modulates the IL23 signaling pathway. Nomelcitinib is used for research on multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, psoriasis, psoriatic arthritis, Crohn's disease, Sjögren's syndrome, and scleroderma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
